Mathieu, V.; Wauthoz, N.; Lefranc, F.; Niemann, H.; Amighi, K.; Kiss, R.; Proksch, P.
Cyclic versus Hemi-Bastadins. Pleiotropic Anti-Cancer Effects: from Apoptosis to Anti-Angiogenic and Anti-Migratory Effects. Molecules 2013, 18, 3543-3561.
https://doi.org/10.3390/molecules18033543
AMA Style
Mathieu V, Wauthoz N, Lefranc F, Niemann H, Amighi K, Kiss R, Proksch P.
Cyclic versus Hemi-Bastadins. Pleiotropic Anti-Cancer Effects: from Apoptosis to Anti-Angiogenic and Anti-Migratory Effects. Molecules. 2013; 18(3):3543-3561.
https://doi.org/10.3390/molecules18033543
Chicago/Turabian Style
Mathieu, Véronique, Nathalie Wauthoz, Florence Lefranc, Hendrik Niemann, Karim Amighi, Robert Kiss, and Peter Proksch.
2013. "Cyclic versus Hemi-Bastadins. Pleiotropic Anti-Cancer Effects: from Apoptosis to Anti-Angiogenic and Anti-Migratory Effects" Molecules 18, no. 3: 3543-3561.
https://doi.org/10.3390/molecules18033543
APA Style
Mathieu, V., Wauthoz, N., Lefranc, F., Niemann, H., Amighi, K., Kiss, R., & Proksch, P.
(2013). Cyclic versus Hemi-Bastadins. Pleiotropic Anti-Cancer Effects: from Apoptosis to Anti-Angiogenic and Anti-Migratory Effects. Molecules, 18(3), 3543-3561.
https://doi.org/10.3390/molecules18033543
